Babler Martin Insider Trades

Insider Trading History

Track insider trading activity for Babler Martin. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Alumis
Alumis ALMS
President, CEO And Chairman
Holding Value $15.2M 745,875 shares
Last Trade
Jan 26, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$19.6M 745,875 shares
$26.31
$20.39
89bio
89bio ETNB
Director
Holding Value $0 0 shares
Last Trade
Oct 30, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$1.84M 124,100 shares
$14.84
$14.84
Alumis
Alumis ALMS
President, CEO And Chairman
Holding Value $13.5M 662,000 shares
Last Trade
Jul 29, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.21M 812,000 shares
$3.95
$20.39
Prelude Therapeutics
Prelude Therapeutics PRLD
Director
Holding Value $155k 38,000 shares
Last Trade
Jun 12, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$39.5k 38,000 shares
$1.04
$4.08
Alumis
Alumis ALMS
President, CEO And Chairman
Holding Value $2.17M 106,454 shares
Last Trade
Apr 01, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$113k 15,650 shares
$7.24
$20.39
89bio
89bio ETNB
Director
Holding Value $837k 56,400 shares
Last Trade
Feb 03, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$541k 56,400 shares
$9.60
$14.84
Prelude Therapeutics
Prelude Therapeutics PRLD
Director
Holding Value $95.9k 23,500 shares
Last Trade
Jun 14, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$91.7k 23,500 shares
$3.90
$4.08
89bio
89bio ETNB
Director
Holding Value $1M 67,700 shares
Last Trade
May 02, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$600k 67,700 shares
$8.86
$14.84
Prelude Therapeutics
Prelude Therapeutics PRLD
Director
Holding Value $95.9k 23,500 shares
Last Trade
Jun 16, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$131k 23,500 shares
$5.56
$4.08
Neoleukin Therapeutics
Neoleukin Therapeutics NLTX
Director
Holding Value $87.3k 25,000 shares
Last Trade
Jun 08, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$3.49
Neurogene
Neurogene NGNE
Director
Holding Value $687k 25,000 shares
Last Trade
Jun 08, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$395k 25,000 shares
$15.80
$27.48
Prelude Therapeutics
Prelude Therapeutics PRLD
Director
Holding Value $128k 31,293 shares
Last Trade
Jun 17, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$297k 62,586 shares
$4.74
$4.08
Neoleukin Therapeutics
Neoleukin Therapeutics NLTX
Director
Holding Value $87.3k 25,000 shares
Last Trade
May 12, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$3.49
Prelude Therapeutics
Prelude Therapeutics PRLD
Director
Holding Value $149k 36,400 shares
Last Trade
Jul 19, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.14M 36,400 shares
$31.37
$4.08
Neoleukin Therapeutics
Neoleukin Therapeutics NLTX
Director
Holding Value $87.3k 25,000 shares
Last Trade
May 11, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$3.49
Neoleukin Therapeutics
Neoleukin Therapeutics NLTX
Director
Holding Value $175k 50,000 shares
Last Trade
Sep 08, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$3.49
Infinity Pharmaceuticals
Infinity Pharmaceuticals INFI
Director
Holding Value $120 15,000 shares
Last Trade
Jun 11, 2013 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$260k 15,000 shares
$17.34
$0.01
Infinity Pharmaceuticals
Infinity Pharmaceuticals INFI
Director
Holding Value $48 6,000 shares
Last Trade
May 16, 2012 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$104k 8,000 shares
$12.94
$0.01
Infinity Pharmaceuticals
Infinity Pharmaceuticals INFI
Director
Holding Value $48 6,000 shares
Last Trade
May 18, 2011 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$54.4k 8,000 shares
$6.80
$0.01
Infinity Pharmaceuticals
Infinity Pharmaceuticals INFI
Director
Holding Value $45 5,625 shares
Last Trade
May 25, 2010 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$50.6k 7,500 shares
$6.74
$0.01

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up